SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech informs about press release

16 Apr 2022 Evaluate

Windlas Biotech has informed about press release titled - Windlas Biotech received certificate of Good Manufacturing Practices (GMP) from SAHPRA (South African Health Products Regulatory Authority).

The above information is a part of company’s filings submitted to BSE.

Windlas Biotech Share Price

810.80 -7.60 (-0.93%)
11-Jun-2026 14:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.85
Dr. Reddys Lab 1277.20
Cipla 1386.00
Zydus Lifesciences 1110.00
Lupin 2281.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: